Rodolphe Barrangou
Rodolphe Barrangou is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research in the Department of Food, Bioprocessing and Nutrition Sciences at North Carolina State University; Co-Founder and Chief Executive Officer of CRISPR Biotechnologies; Co-Founder and Chief Scientific Officer of Ancilia Biosciences; Co-Founder, President and Chief Scientific Officer of TreeCo; and Co-Founder and member of the Scientific Advisory Board of Intellia Therapeutics. His research focuses on CRISPR-Cas9 in bacteria.In 2017, Barrangou was named Editor-in-Chief of The CRISPR Journal, a peer-reviewed journal covering the field of genome editing and CRISPR research, which debuted in February 2018.
He was elected as a member into the National Academy of Sciences in 2018. He was also elected into the National Academy of Engineering in 2019 for the discovery of CRISPR-Cas genome editing and engineering microbes, plants, and animals for food and other applications. Provided by Wikipedia
-
1
-
2
-
3
-
4
-
5by Courtney Klotz, Courtney Klotz, Yong Jun Goh, Sarah O’Flaherty, Brant Johnson, Brant Johnson, Rodolphe Barrangou, Rodolphe Barrangou, Rodolphe BarrangouGet full text
Published 2020-03-01
Article -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18by Brant R. Johnson, Brant R. Johnson, Sarah O’Flaherty, Yong Jun Goh, Ian Carroll, Ian Carroll, Rodolphe Barrangou, Rodolphe Barrangou, Todd R. Klaenhammer, Todd R. Klaenhammer, Todd R. KlaenhammerGet full text
Published 2017-06-01
Article -
19
-
20